Pure Global AI
Manufacturer profile

OK BIOTECH CO., LTD.

TaiwanTaiwan, Province of China20 products registeredFeb 21, 2020 – Aug 22, 2024
VerifiedTFDA · Taiwan Food and Drug Administration registry
20
Total products
20
Product types
20
Active products
Aug 2024
Latest registration
Company details
Address
新竹市東區公道五路2段91號、91號2-6樓
Regulatory footprint
Search OK BIOTECH CO., LTD. across other regulatory registries
Recent registrations
Latest 5 products registered by this manufacturer
Most popular products
Products with most registrations
Authorized representatives
Taiwan authorized representatives for this manufacturer
Recent registered products
Most recent products (showing top 20)
"Kangyang" Pouver blood glucose monitoring system
Registered: Aug 22, 2024 • Expires: Dec 19, 2029
Risk Class
Class 2
AR
OK BIOTECH CO., LTD.
OKmeter Vita Blood Glucose Monitoring System
Registered: Sep 21, 2023 • Expires: Sep 21, 2028
Risk Class
Class 2
Type
MD
AR
OK BIOTECH CO., LTD.
Easy to measure sugar blood glucose monitoring system
Registered: Apr 24, 2023 • Expires: Apr 24, 2028
Risk Class
Class 2
AR
OK BIOTECH CO., LTD.
Oak unlimited blood glucose monitoring system
Registered: Mar 03, 2023 • Expires: Aug 24, 2026
Risk Class
Class 2
AR
OK BIOTECH CO., LTD.
BIONANO Blood Glucose Monitoring System
Registered: Feb 20, 2023 • Expires: Feb 20, 2028
Risk Class
Class 2
Type
MD
AR
OK BIOTECH CO., LTD.
Smart quick blood glucose monitoring system
Registered: Jan 18, 2023 • Expires: Dec 10, 2025
Risk Class
Class 2
AR
OK BIOTECH CO., LTD.
Portuguese blood glucose monitoring system
Registered: Oct 18, 2021 • Expires: Oct 18, 2026
Risk Class
Class 2
AR
OK BIOTECH CO., LTD.
Kangyan Parker blood glucose monitoring system
Registered: Oct 08, 2021 • Expires: Oct 08, 2026
Risk Class
Class 2
AR
OK BIOTECH CO., LTD.
Oak Measurement Blood Glucose Monitoring System
Registered: Aug 24, 2021 • Expires: Aug 24, 2026
Risk Class
Class 2
AR
OK BIOTECH CO., LTD.
Jiadak blood glucose monitoring system
Registered: Jul 27, 2021 • Expires: Aug 27, 2026
Risk Class
Class 2
AR
OK BIOTECH CO., LTD.
Duncon blood glucose monitoring system
Registered: Jul 16, 2021 • Expires: Jul 16, 2026
Risk Class
Class 2
AR
OK BIOTECH CO., LTD.
Deensheng blood glucose monitoring system
Registered: Jul 15, 2021 • Expires: Jul 15, 2026
Risk Class
Class 2
AR
OK BIOTECH CO., LTD.
Gardack blood glucose monitoring system
Registered: Jul 15, 2021 • Expires: Jul 15, 2026
Risk Class
Class 2
AR
OK BIOTECH CO., LTD.
Glucosa-sensitive glucose monitoring system
Registered: Jun 15, 2021 • Expires: Dec 10, 2025
Risk Class
Class 2
AR
OK BIOTECH CO., LTD.
OKcare Multi-Frequency Therapy Device
Registered: Mar 02, 2021 • Expires: Mar 02, 2026
Risk Class
Class 2
Type
MD
AR
OK BIOTECH CO., LTD.
Rapid glucose monitoring system
Registered: Dec 10, 2020 • Expires: Dec 10, 2025
Risk Class
Class 2
AR
OK BIOTECH CO., LTD.
Oakpoint Views Blood Glucose Monitoring System
Registered: Jul 03, 2020 • Expires: Jul 03, 2025
Risk Class
Class 2
AR
OK BIOTECH CO., LTD.
Golden glucose solution (unsterilized)
Registered: Jun 05, 2020 • Expires: Jun 05, 2025
Risk Class
Class 1
AR
GOLDEN SMART HOME TECHNOLOGY CORP.
Oak Health Blood Glucose Monitoring System
Registered: Apr 17, 2020 • Expires: Apr 17, 2025
Risk Class
Class 2
AR
OK BIOTECH CO., LTD.
"OKmeter"Hearing Aid (Non-Sterile)
Registered: Feb 21, 2020 • Expires: Feb 21, 2025
Risk Class
Class 1
Type
MD
AR
OK BIOTECH CO., LTD.
About this profile

Explore comprehensive manufacturer profile for OK BIOTECH CO., LTD. based in Taiwan, Province of China through Pure Global AI's free Taiwan medical device database. This manufacturer has 20 products registered in Taiwan across 20 unique product categories. Their regulatory history spans from Feb 21, 2020 to Aug 22, 2024.

This page provides detailed insights including 5 recent product registrations, 5 most popular products with "Kangyang" Pouver blood glucose monitoring system having 1 registrations, and 2 authorized representatives including OK BIOTECH CO., LTD.. Pure Global AI offers free access to Taiwan's medical device database, enabling global MedTech companies to analyze market dynamics and identify opportunities.